Transposon DNA sequences facilitate the tissue-specific gene transfer of circulating tumor DNA between human cells

Nucleic Acids Res. 2024 Jul 22;52(13):7539-7555. doi: 10.1093/nar/gkae427.

Abstract

The exchange of genes between cells is known to play an important physiological and pathological role in many organisms. We show that circulating tumor DNA (ctDNA) facilitates cell-specific gene transfer between human cancer cells and explain part of the mechanisms behind this phenomenon. As ctDNA migrates into the nucleus, genetic information is transferred. Cell targeting and ctDNA integration require ERVL, SINE or LINE DNA sequences. Chemically manufactured AluSp and MER11C sequences replicated multiple myeloma (MM) ctDNA cell targeting and integration. Additionally, we found that ctDNA may alter the treatment response of MM and pancreatic cancer models. This study shows that retrotransposon DNA sequences promote cancer gene transfer. However, because cell-free DNA has been detected in physiological and other pathological conditions, our findings have a broader impact than just cancer. Furthermore, the discovery that transposon DNA sequences mediate tissue-specific targeting will open up a new avenue for the delivery of genes and therapies.

MeSH terms

  • Animals
  • Cell Line, Tumor
  • Circulating Tumor DNA* / blood
  • Circulating Tumor DNA* / genetics
  • DNA Transposable Elements* / genetics
  • Gene Transfer Techniques
  • Humans
  • Mice
  • Multiple Myeloma / genetics
  • Multiple Myeloma / therapy
  • Organ Specificity / genetics
  • Pancreatic Neoplasms / genetics
  • Pancreatic Neoplasms / therapy
  • Retroelements / genetics

Substances

  • Circulating Tumor DNA
  • DNA Transposable Elements
  • Retroelements